Cancer
Conditions
Interventions
Cancer medical tharapy
Sponsors
Department of Surgery, Fukushima Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Case signedinformed consent of the patients for the registration 2.Case confirmed by pathological diagnosis 3.younger than 85 years old, 20 years old or older 4.Case planned for cancer treatment of chemothareapy, hormone tharapy, or targeted therapy 5.Case with measurable primary lesions 6.Case that survival more than 6 months isanticipated 7.Case with PS 0 or 1 8.Case with a satisfactory function of a heart/liver/kidney/bone marrow ant to satisfy the next condition Hb:more than 8g/dl AST(GOT), ALT(GPT):less than 2.5 times of the normal value upper limit of the institution Crea:less than 1.5 mg/dl
Exclusion criteria
Exclusion criteria: 1.Case with active other malignancies 2.Case with past history of drug allergy or hypersensitivity 3.Case during pregnancy or lactation 4.Case with a history of operation of A cerebral aneurysm, a cardiac pacemaker, or a internal metal 5.Case with infectious disease 6.Case judged inappropriate by physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| response rate | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical benefit rate | — |
Countries
Japan
Contacts
Public ContactNoriko Abe
Fukushima Medical University Department of Surgery
Outcome results
None listed